IL6 and metabolic dysfunction-associated steatotic liver disease: A recent study on adolescents with NAFLD, diagnosed by ultrasonography and fibroscan, suggested that serum P1NP and IL-6 along with routine chemistry tests can be used as predictors for assessing steatohepatitis and fibrosis [9].